Gerald W. Shipps, JR.,Xiaohua Huang,Yongqi Deng,Liang Zhu,Alan B. Cooper,Binyuan Sun,Abdelghani Achab,Sie-Mun Lo
申请号：
US13994224
公开号：
US20130261125A1
申请日:
2011.12.16
申请国别(地区):
US
年份:
2013
代理人:
摘要：
The present invention provides a compound of the Formula I, or a pharmaceutically acceptable salt, solvate or ester thereof, wherein R, R1, R2, R3, m and are as defined herein. The compounds are ERK inhibitors. Also disclosed are pharmaceutical compositions that comprise the above compounds, and methods of treating cancer using the same.
